Johnson Pharmacare
0.64
0.00(0.00%)
Market Cap₹35.20 Cr
PE Ratio-63.00
Company Performance:
1D0.00%
1M-17.95%
6M-33.33%
1Y-42.34%
5Y+137.04%
View Company Insightsright
Latest news about Johnson Pharmacare
Johnson Pharmacare Reports Wider Net Loss in Q1 FY2026, Expenses Rise Jul 23, 2025
Johnson Pharmacare Limited reported a net loss of Rs. 5.34 lacs for Q1 FY2026, compared to Rs. 3.99 lacs in Q1 FY2025. The company had no revenue from operations, while total expenses increased to Rs. 5.34 lacs from Rs. 3.99 lacs year-over-year. Other expenses rose to Rs. 5.04 lacs, and employee benefit expenses were Rs. 0.30 lacs. The company's paid-up equity share capital remains at Rs. 5,500 lacs. The Board of Directors approved these unaudited results on July 23, 2025, after review by the Audit Committee and limited review by statutory auditors.
Johnson & Johnson's Talc Claims Bankruptcy Plan Rejected for Third Time Apr 01, 2025
Johnson & Johnson Secures ₹3.34 Crore Victory in Delhi High Court Counterfeit Case Mar 12, 2025
Johnson & Johnson Faces Crucial Moment in $9 Billion Baby Powder Settlement Feb 19, 2025